文献速递神经肿瘤神经重症

JAM-A在胶质母细胞瘤中作为女性小胶质细胞肿瘤抑制因子

JAM-A functions as a female microglial tumor suppressor in glioblastoma.
PubMed 文献 · Neuro Oncol · 2020-01-01

该研究在雄性及雌性野生型和JAM-A缺陷小鼠颅内移植同源胶质瘤细胞系GL261和SB28,评估生存期及肿瘤内小胶质细胞活化差异,并进行RNA测序。发现JAM-A缺陷雌鼠较野生型雌鼠及JAM-A缺陷雄鼠和野生型雄鼠更快死于胶质母细胞瘤,且雌性JAM-A缺陷小胶质细胞更活化,Fizz1和Ifi202b表达升高。结论提示JAM-A在女性肿瘤微环境中抑制致病性小胶质细胞活化。

要点

  • JAM-A缺陷雌鼠胶质瘤生存期缩短
  • 雌性JAM-A缺陷小胶质细胞活化增强
  • Fizz1和Ifi202b在雌性JAM-A缺陷小胶质细胞中高表达

核心结论

  • JAM-A在女性胶质母细胞瘤微环境中发挥抑制致病性小胶质细胞活化的作用。

研究设计与样本

  • 雄性及雌性野生型和JAM-A缺陷小鼠颅内移植同源胶质瘤细胞系GL261和SB28,评估生存期及小胶质细胞活化,并行RNA测序。

主要发现

  • JAM-A缺陷雌鼠较野生型雌鼠、JAM-A缺陷雄鼠和野生型雄鼠更快死于胶质母细胞瘤。
  • 肿瘤内分析显示雌性JAM-A缺陷小胶质细胞更活化。
  • RNA测序发现Fizz1和Ifi202b在JAM-A缺陷雌性小胶质细胞中表达升高,并在体外和体内验证。

临床怎么用

  • 提示胶质母细胞瘤微环境存在性别差异,JAM-A可能作为女性患者小胶质细胞靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glioblastoma (GBM) is the most aggressive primary brain tumor and has a dismal prognosis. Previously, we identified that junctional adhesion molecule A (JAM-A), a cell adhesion molecule, is highly elevated in human GBM cancer stem cells and predicts poor patient prognosis. While JAM-A is also highly expressed in other cells in the tumor microenvironment, specifically microglia and macrophages, how JAM-A expression in these cells affects tumor growth has yet to be determined. The goal of this study was to understand the role of microenvironmental JAM-A in mediating GBM growth. METHODS: Male and female wild-type (WT) and JAM-A-deficient mice were transplanted intracranially with the syngeneic glioma cell lines GL261 and SB28 and were assessed for differences in survival and microglial activation in tumors and in vitro. RNA-sequencing was performed to identify differentially regulated genes among all genotypes, and differences were validated in vitro and in vivo. RESULTS: We found that JAM-A-deficient female mice succumbed to GBM more quickly compared with WT females and JAM-A-deficient and male WT mice. Analysis of microglia in the tumors revealed that female JAM-A-deficient microglia were more activated, and RNA-sequencing identified elevated expression of Fizz1 and Ifi202b specifically in JAM-A-deficient female microglia. CONCLUSIONS: Our findings suggest that JAM-A functions to suppress pathogenic microglial activation in the female tumor microenvironment, highlighting an emerging role for sex differences in the GBM microenvironment and suggesting that sex differences extend beyond previously reported tumor cell-intrinsic differences.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Turaga SM, Silver DJ, Bayik D, et al. JAM-A functions as a female microglial tumor suppressor in glioblastoma. Neuro Oncol. 2020. PMID: 32592484. doi:10.1093/neuonc/noaa148

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。